Zhejiang Huahai Stock Hits Day Low of CNY 15.30 Amid Price Pressure

Zhejiang Huahai Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.47% on March 20, 2026. The stock reached an intraday low of CNY 15.30, reflecting ongoing challenges in its performance metrics. Over the past week, the stock has decreased by 4.26%, and its year-to-date performance shows a decline of 9.84%. In comparison to the broader market, represented by the China Shanghai Composite, which fell by 1.24% today, Zhejiang Huahai's performance has been significantly weaker. The company has struggled with a high debt-to-equity ratio and has reported a decline in net sales of 11.88%. Additionally, its operating profit has seen a negative trend over the last five years, contributing to a return on equity of just 4.24%. Despite a dividend yield of 1.59%, the stock's valuation appears elevated with a price-to-book ratio of 2.40. Overall, the company's financial indicators suggest a challenging environment as it continues to navigate through its current market position.